TURKEY IS IN THE TOP 5 IN EUROPE IN BONE MARROW TRANSPLANT SURGERY

.
.
TURKEY IS IN THE TOP 5 IN EUROPE IN MARROW TRANSPLANTATION

Turkey Medicals member JCI Antalya hospital Hematology Specialist Professor Doctor said, “Our country has very clearly made a big breakthrough in marrow transplant in Turkey and we are now in the top 5 in Europe. It is possible to say this with pride,” he explained.

Prof. Dr. made evaluations in Kyrenia, Turkish Republic of North Cyprus, where he came to participate in the 6th Hematological Oncology Congress.

Hematological Oncology are performed successfully each year that the Congress this year, is home to three hundred participants, indicating that Professor Doctor in Congress, especially leukemia, acute and chronic leukemia, lymphoma and multiple miyolo indicated that the management of the treatment of diseases such as was discussed in detail.

Prof. Doctor stated that they had a productive congress accompanied by many doyen surgeons who are experts in their field.

The health field, especially in rational drug applications, Prof. Dr. also pointing to the fore recently, general oncology, cancer almost a lot in the last 10 years there have been more targeted groups in the molecule and that he underlined that gives me great hope to these patients.

Prof. Dr. He noted that a period has now begun in which rational molecules with a lower side effect profile than other healthy cells are being used more intensively, focusing especially on tumor cells, rather than a single chemotherapy for all patients.

Emphasizing that this period is a period when standard chemotherapies have been moved away as much as possible, Prof. Dr. said that this has started the era of special treatments.

“So two patients may have the same diagnosis, but because the genetic characteristics of their tumors are different from each other, they may respond to different medications. We aim to evaluate them with different methods in advance and apply right treatment to the right patient. We are now at the point of successfully implementing this in Antalya city, Turkey,” he said.

.
WE ARE IN THE TOP 5 IN EUROPE

Prof. Doctor, he continued as follows:

“Turkey has made a great breakthrough in marrow transplantation and we are in the top 5 in Europe. It is possible to say this with pride. Today, as of 2018, 5 thousand stem cell transplants can be performed annually in our country. Great developments have been made in this field in the last 15 years, especially with the support of the Ministry of Health in Turkey. The number of both pediatric and adult centers has increased very rapidly. The number of our teachers working on this issue has increased. Especially the transplantation is very successful, we also do it at very reasonable prices compared to Europe and the USA.”

Reminding that these developments in the field of bone marrow transplantation in Turkey have become an important door of hope for Turkey health tourism, Prof. Doctor stated that a very large number of patients from abroad have come to Turkey for transplantation and have regained their health.

Emphasizing that the developments in the field of medicine in recent years are important reflections, Prof. Dr. said, “We were a little dependent on Europe and the USA for marrow transplants that we would do from someone else because we were behind before and did not have our own database. This problem has been solved to a great extent with the TÜRKÖK Project, which was commissioned in April 2016. We are now able to find a compatible transmitter from our own country sources for roughly 60 percent of those who do not have a sister transmitter in Turkey. We are able to achieve this at a lower cost of 1 in 5 compared to the stem cells we provide from abroad,” he said.

.

. .

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)